Clostridium difficile colitis associated with the use of antineoplastic agents S. D. MillerH. J. Koornhof Original Articles Pages: 10 - 13
Assay of type-specific M antigens on whole group A streptococci H. MiörnerK. Nivenius Larsson Original Articles Pages: 14 - 18
Subcellular fractions in rubella immunoassays H. TuokkoV. ToivonenA. Salmi Original Articles Pages: 19 - 24
Direct radioimmunoassay of antibody against hepatitis B core antigen using32P-labelled core particles W. WolffW. H. Gerlich Original Articles Pages: 25 - 29
Use of hepatitis B core antigen produced inEscherichia coli to detect immunoglobulin M specific antibodies in an enzyme-linked immunosorbent assay G. HascheJ. StecherH. W. Doerr Original Articles Pages: 30 - 34
Serum and cerebrospinal fluid levels of cefotaxime in neurosurgical patients W. SachsenheimerA. Kühner Correspondence Pages: 36 - 37
Susceptibility ofBacteroides fragilis to cefotaxime and piperacillin: Tentative interpretative standards for the disc-diffusion test I. LuzziA. PantostiG. Panichi Correspondence Pages: 37 - 39
In vitro activity of temocillin (BRL 17421) againstChlamydia trachomatis K. H. TjiamB. Y. M. van HeijstM. F. Michel Correspondence Pages: 39 - 40
Detection of resistant isolates ofCampylobacter jejuni by the disc susceptibility method M. RogolJ. Michel Correspondence Pages: 40 - 42
Computer monitoring of gentamicin resistance in Czechoslovakia from 1972 to 1982 V. KrčméryJ. JanouskovaR. Menkyna Correspondence Pages: 42 - 43
Differentiation in throat cultures of group C and G streptococci fromStreptococcus milleri with identical antigens C. BucherA. von Graevenitz Correspondence Pages: 44 - 45
Persistence of immunoglobulin M antibody to hepatitis A virus and relapse of hepatitis A infection C. CornuM. E. LamyL. Galanti Correspondence Pages: 45 - 46
Reduced efficacy of sulfitolysed intravenous immunoglobulin W. StephanH. Dichtelmüller Correspondence Pages: 47 - 47
Preliminary evaluation of a passive hemagglutionation assay and enzyme-linked immunosorbent assay for actinomycetoma caused byNocardia brasiliensis H. ZlotnikH. F. HavasH. R. Buckley Correspondence Pages: 48 - 50
In vitro activity of teicoplanin and vancomycin against anaerobes Y. GlupczynskiM. LabbeE. Yourassowsky Correspondence Pages: 50 - 51
Clinical and epidemiological survey of acquired immune deficiency syndrome in Europe M. P. GlauserP. Francioli OriginalPaper Pages: 55 - 58
Acquired immune deficiency syndrome in the Federal Republic of Germany J. L'age-Stehr OriginalPaper Pages: 61 - 61
Acquired immune deficiency syndrome in the Netherlands C. M. Vandenbroucke-GraulsJ. Verhoef OriginalPaper Pages: 62 - 62
Acquired immune deficiency syndrome in Scandinavia H. RepoS. -L. ValleT. Pettersson OriginalPaper Pages: 65 - 65
Beta-2 microglobulin: A sensitive non-specific marker of acquired immune deficiency syndrome P. FrancioliF. ClémentM. P. Glauser OriginalPaper Pages: 68 - 69
Urinary neopterin in the diagnosis of acquired immune deficiency syndrome D. FuchsA. HausenH. Wachter OriginalPaper Pages: 70 - 71
Persistent lymphadenopathy in patients at risk of contracting acquired immune deficiency syndrome J. P. ClauvelJ. L. CoudercJ. C. Brouet OriginalPaper Pages: 72 - 72
Immunological studies in homosexual men with unexplained lymphadenopathy B. J. MangerG. R. BurmesterJ. R. Kalden OriginalPaper Pages: 73 - 74
Histopathological study of lymph nodes in patients with lymphadenopathy or acquired immune deficiency syndrome C. MarcheS. KernbaumD. Vittecoq OriginalPaper Pages: 75 - 76
Presence of viral antibodies to the human lymphoma-leukemia virus in patients with acquired immune deficiency syndrome M. BornK. von der HelmF. Deinhardt OriginalPaper Pages: 77 - 78
Searching for the cause of the acquired immune deficiency syndrome R. D. Leavitt Review Pages: 79 - 84